NASDAQ:TBIO - Nasdaq - US1920032000 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -49.54M | -47.72M | -48.47M | -38.96M | -18.01M | |||
Depreciation Amortization | 2.34M | 2.32M | 1.67M | 908.00K | 866.00K | |||
Change In Working Capital | 4.23M | -7.77M | 2.13M | -3.04M | -20.00K | |||
Interest Paid | 1.50M | 2.23M | 1.38M | 825.00K | 464.00K | |||
Taxes Paid | 20.00K | 24.00K | N/A | N/A | 0.00 | |||
Other non cash items | 21.19M | 18.50M | 5.96M | 4.39M | 1.78M | |||
OPERATING CASH FLOW | -21.78M | -34.67M | -38.72M | -36.70M | -15.38M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -939.00K | -1.98M | -4.47M | -1.85M | -204.00K | |||
Other Investing Activity | -2.40M | -3.76M | -13.54M | -13.19M | N/A | |||
INVESTING CASH FLOW | -3.34M | -5.74M | -18.01M | -15.04M | -204.00K | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | -15.10M | -15.09M | 4.68M | 9.79M | -107.00K | |||
Stock Issued/Repurchased | -43.00K | 26.66M | 580.00K | 112.66M | 11.00K | |||
Other Financing Activity | -8.13M | 0.00 | -752.00K | -1.37M | 0.00 | |||
FINANCING CASH FLOW | -15.16M | 11.56M | 4.51M | 121.08M | -96.00K | |||
Exchange Rate Effect | N/A | -3.00K | N/A | N/A | N/A | |||
CHANGE IN CASH | -40.29M | -28.85M | -52.21M | 69.34M | -15.68M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | -21.78M | -34.67M | -38.72M | -36.70M | -15.38M | |||
Capital Expenditure | -939.00K | -1.98M | -4.47M | -1.85M | -204.00K | |||
FREE CASH FLOW | -22.72M | -36.65M | -43.18M | -38.55M | -15.59M |
All data in USD